Covered recipient · General Payments record
JAMES REEVES
Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology
A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.
Saved only in this browser. No account or alerts.
General Payments · PY2020 · Entire year
$6,513.86
71 records · 0 disputed
“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”
— Centers for Medicare & Medicaid Services, Open Payments
A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.
These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.
A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.
How these totals are calculated
- This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Methodology & Data — sourcing, labeling, and limitations.
Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗
By nature of payment
PY2020 · entire year · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $3,200.00 | 2 |
| Food and Beverage | $2,259.81 | 64 |
| Education | $806.44 | 4 |
| Compensation for serving as faculty or as a speaker for an accredited or certified continuing education program | $247.61 | 1 |
By paying entity
PY2020 · entire year · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Eisai Inc. | $3,250.00 | 3 |
| E.R. Squibb & Sons, L.L.C. | $564.00 | 1 |
| AstraZeneca Pharmaceuticals LP | $433.85 | 4 |
| Celgene Corporation | $396.18 | 4 |
| Foundation Medicine, Inc. | $295.22 | 2 |
| Daiichi Sankyo Inc. | $243.62 | 5 |
| Merck Sharp & Dohme Corporation | $164.37 | 6 |
| Incyte Corporation | $156.90 | 5 |
| Exelixis Inc. | $150.00 | 1 |
| Adaptive Biotechnologies Corporation | $141.92 | 1 |
| AbbVie Inc. | $115.25 | 2 |
| GENZYME CORPORATION | $107.20 | 6 |
| Novartis Pharmaceuticals Corporation | $95.08 | 1 |
| Seagen Inc. | $61.56 | 3 |
| Janssen Biotech, Inc. | $56.43 | 4 |
| PFIZER INC. | $56.18 | 4 |
| Karyopharm Therapeutics Inc. | $32.12 | 2 |
| BeiGene USA, Inc. | $26.82 | 2 |
| Amgen Inc. | $25.79 | 2 |
| Lilly USA, LLC | $24.99 | 1 |
| GlaxoSmithKline, LLC. | $18.70 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $18.69 | 1 |
| Veracyte, Inc. | $15.23 | 5 |
| Aurobindo Pharma USA, Inc. | $13.36 | 1 |
| ARRAY BIOPHARMA INC | $12.89 | 1 |
| Blueprint Medicines Corporation | $12.65 | 1 |
| Astellas Pharma US Inc | $12.54 | 1 |
| Octapharma USA, Inc. | $12.32 | 1 |
Page 2 of 2; records 51–71 of 71 matching records. This page contains 21 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.
IndustryPayments · General Payments
JAMES REEVES
NPI 1447233986 · CMS profile ID 20180
Allopathic & Osteopathic Physicians / Internal Medicine / Medical Oncology
FORT MYERS, FL
A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.
A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.
General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types
Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00
Page 2 of 2; records 51–71 of 71 matching records. This page contains 21 records (maximum 50), not the full filtered export.
Filtered page: https://industrypayments.org/provider/npi-1447233986?year=2020&recipient=provider&page=2#records-h
CMS source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019
Cite these filtered records
The citation includes this program year, filters, data edition, and page of results.
- Plain
- JAMES REEVES, NPI 1447233986, CMS profile ID 20180. General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 2; records 51–71 of 71 matching records. This page contains 21 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1447233986?year=2020&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019.
- APA 7
- IndustryPayments. (2026). JAMES REEVES, NPI 1447233986, CMS profile ID 20180. General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 2; records 51–71 of 71 matching records. This page contains 21 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1447233986?year=2020&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019.
- Bluebook
- JAMES REEVES, NPI 1447233986, CMS profile ID 20180, IndustryPayments, General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 2; records 51–71 of 71 matching records. This page contains 21 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019. https://industrypayments.org/provider/npi-1447233986?year=2020&recipient=provider&page=2#records-h.
Centers for Medicare & Medicaid Services, Open Payments
Citation formats are provided for reference; check the requirements of your publication.
Payment records · PY2020
Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them
General Payments · PY2020 · Physicians and non-physician practitioners · CMS publication 2026-06-30
71 matching records · $6,513.86 reported total · 0 disputed
Nature of payment: All payment types
Records imported here (UTC).
CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.
Showing records 51–71 of 71.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Publication flags | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|---|
| PFIZER INC. | $11.25 | 03/09/2020 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 743708137 | CMS |
| AstraZeneca Pharmaceuticals LP | $116.93 | 02/25/2020 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 736354779 | CMS |
| Eisai Inc. | $500.00 | 02/15/2020 | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 751343183 | CMS |
| Eisai Inc. | $50.00 | 02/15/2020 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 751343185 | CMS |
| Eisai Inc. | $2,700.00 | 02/15/2020 | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 751346961 | CMS |
| AstraZeneca Pharmaceuticals LP | $110.15 | 02/13/2020 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 736407063 | CMS |
| Merck Sharp & Dohme Corporation | $53.58 | 02/12/2020 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 747779367 | CMS |
| Celgene Corporation | $242.00 | 02/11/2020 | Education | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 727856975 | CMS |
| Veracyte, Inc. | $13.08 | 02/07/2020 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 753805875 | CMS |
| Incyte Corporation | $100.09 | 02/06/2020 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 745803664 | CMS |
| Astellas Pharma US Inc | $12.54 | 02/03/2020 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 718373247 | CMS |
| Foundation Medicine, Inc. | $247.61 | 01/30/2020 | Compensation for serving as faculty or as a speaker for an accredited or certified continuing education program | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 714557813 | CMS |
| Daiichi Sankyo Inc. | $103.40 | 01/28/2020 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 739509377 | CMS |
| AbbVie Inc. | $22.89 | 01/27/2020 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 722091915 | CMS |
| Veracyte, Inc. | $0.55 | 01/24/2020 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 753805873 | CMS |
| Daiichi Sankyo Inc. | $125.00 | 01/17/2020 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 739473099 | CMS |
| AbbVie Inc. | $92.36 | 01/16/2020 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 722091913 | CMS |
| Merck Sharp & Dohme Corporation | $19.94 | 01/16/2020 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 747713889 | CMS |
| Veracyte, Inc. | $0.52 | 01/15/2020 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 753805871 | CMS |
| Celgene Corporation | $111.93 | 01/14/2020 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 727856957 | CMS |
| Veracyte, Inc. | $0.54 | 01/08/2020 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 753805869 | CMS |
By program year
All program years on this page · sorted by year
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2020, 2021, 2022, 2024
Source files and profile matching
- Generated from
- OP_DTL_GNRL_PGYR2024_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.
Research Payments
One row per program year and role, newest year first · amounts for the two roles are never added together
| Program year | Role | Amount | Records |
|---|---|---|---|
| PY2025 | Principal investigator | $6,067.58 | 5 |
| PY2024 | Principal investigator | $96,735.75 | 14 |
| PY2023 | Principal investigator | $167,404.93 | 51 |
| PY2022 | Principal investigator | $940,400.68 | 229 |
| PY2021 | Recipient | $812.50 | 1 |
| PY2021 | Principal investigator | $1,554,036.25 | 224 |
| PY2020 | Recipient | $2,578.70 | 2 |
| PY2020 | Principal investigator | $2,071,596.05 | 162 |
| PY2019 | Recipient | $15,870.14 | 4 |
| PY2019 | Principal investigator | $2,222,297.28 | 176 |
Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.
“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”
— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224
Research Payments records · PY2025
Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them
5 records in PY2025
| Role | Paying entity | Amount | Date | Recipient | Study | Dispute status | Published | Record ID |
|---|---|---|---|---|---|---|---|---|
| Principal investigator 1 | E.R. Squibb & Sons, L.L.C. | $140.33 | 08/29/2025 | Non-covered Recipient Entity Sarah Cannon Research Institute, Llc | A Randomized, Multicenter, Open-Label, Phase 3 Study of Nivolumab plus Ipilimumab or Nivolumab in Combination with Oxaliplatin plus Fluoropyrimidine versus Oxaliplatin plus Fluoropyrimidine in Subjects with Previously Untreated Advanced or Metastatic Gastric or Gastroesophageal Junction Cancer | No dispute reported | 06/30/2026 | 1235993831 |
| Principal investigator 1 | PFIZER INC. | $22.50 | 07/25/2025 | Non-covered Recipient Entity Sarah Cannon Research Institute LLC | A PHASE 3 RANDOMIZED DOUBLEBLIND PLACEBOCONTROLLED STUDY OF TALAZOPARIB WITH ENZALUTAMIDE IN METASTATIC CASTRATIONRESISTANT PROSTATE CANCER | No dispute reported | 06/30/2026 | 1228844410 |
| Principal investigator 1 | Merck Sharp & Dohme LLC | $195.00 | 05/02/2025 | Non-covered Recipient Entity Florida Cancer Specialists South Region - Research Office | A Phase III Study of Pembrolizumab MK-3475 vs. Chemotherapy in Microsatellite Instability-High MSI-H or Mismatch Repair Deficient dMMR Stage IV Colorectal Carcinoma KEYNOTE-177 | No dispute reported | 06/30/2026 | 1232925893 |
| Principal investigator 1 | Merck Sharp & Dohme LLC | $2,391.00 | 04/23/2025 | Non-covered Recipient Entity Florida Cancer Specialists South Region - Research Office | A Phase III Randomized Open-label Study of Single Agent Pembrolizumab vs Physicians' Choice of Single Agent Docetaxel, Paclitaxel, or Irinotecan in Subjects with Advanced,Metastatic Adenocarcinoma and Squamous Cell Carcinoma of the Esophagus that have Pro | No dispute reported | 06/30/2026 | 1232925843 |
| Principal investigator 1 | SANOFI US SERVICES INC. | $3,318.75 | 01/13/2025 | Non-covered Recipient Entity Sarah Cannon Research Inst LLC | A Phase 3 Randomized, Open-label, Multicenter Study Assessing the Clinical Benefit of Isatuximab (SAR650984) in Combination With Bortezomib (Velcade), Lenalidomide (Revlimid) and Dexamethasone Versus Bortezomib, Lenalidomide and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma (NDMM) Not Eligible for Transplant | No dispute reported | 06/30/2026 | 1226135990 |